Nazan Eras-Erdogan

Dr. Nazan Eras-Erdogan


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2009 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
NENazan Eras-Erdogan
Nazan Eras-Erdogan
EAE. Akbas
E. Akbas
HSH. Senli
H. Senli
SKS. Kul
S. Kul
TÇT. Çolak
T. Çolak

1 January 2019 in Journal of Breast Cancer
Verified
Journal Article
Open access
NENazan Eras-Erdogan
Nazan Eras-Erdogan
FDFerah Tuncel Daloglu
Ferah Tuncel Daloglu
TÇTahsin Çolak
Tahsin Çolak
MGMehmet Guler
Mehmet Guler
EAEtem Akbas
Etem Akbas
Eras N, et al. J Breast Cancer. 2019 Mar;22:e27. https://doi.org/10.4048/jbc.2019.22.e27

1 January 2015 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Closed access
BBBahar Bahar
Bahar Bahar
SKSemra Kahraman
Semra Kahraman
NENazan Eras-Erdogan
Nazan Eras-Erdogan
CPCaroline Pirkevi
Caroline Pirkevi
Background/aim: The aim of this study was to compare the cellular properties of endometrial tissues from fertile patients and patients having at least 3 previous in vitro fertilization failures, during the implantation window. The ultrastructural evaluation of the endometrium in the implantation window may shed light on the complexity of the implantation failure paradigm. Materials and methods: The study involved 23 women, 14 infertile with a clinical diagnosis of repeated implantation failure (RIF) and 9 fertile, defined as the control group. Endometrial samples were examined by transmission electron microscopy (TEM). Results: In the control group, secretory vacuoles and cytoplasmic projections filled with secretory material, called pinopodes, were noted; microvilli were observed on some apical surfaces; and ciliated cells were absent. In the RIF group, the number of pinopodes was remarkably lower, with some of them being immature. Moreover, decidualization of stromal cells was not frequent and fewer epithelial cells with poor secretory vacuoles were discerned. Conclusion: TEM analyses of endometrial samples from the RIF group revealed dramatic differences at the ultrastructural level compared to the controls, which may well be an underlying cause of their infertility.

16 July 2021 in Archives of Medical Science
Verified
Journal Article
Open access
NENazan Eras-Erdogan
Nazan Eras-Erdogan
GTGozde Türkoz
Gozde Türkoz
ATAnil Tombak
Anil Tombak
NTNaci Tiftik
Naci Tiftik
SYSerap Yalin
Serap Yalin
EAEtem Akbas
Etem Akbas
Introduction: Catalase (CAT), an antioxidant enzyme, catalyzes conversion of hydrogen peroxide to water and molecular oxygen, protecting cells against oxidative stress. The aim of this study was to investigate the possible association between CAT C262T polymorphism in the promoter region of the CAT gene and leukemia risk and to determine the relationship between CAT genotypes and CAT enzyme activities.Material and methods: Genotypes of 102 cases and 112 healthy controls’ genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism methods. Catalase activity was measured with the method of Aebi.Results: The frequencies of the T allele among the cases and controls were 28.4% and 25.9%, respectively (p = 0.75). The frequencies of CC, CT, and TT among cases were 57.8%, 27.4%, and 14.7%, respectively, while in controls, the frequencies of CC, CT, and TT were 54.4%, 39.3%, and 6.3%, respectively, which were not significantly different. Although CAT enzyme activity was lower in leukemia patients with TT genotypes than in controls, this did not reach statistical significance (p = 0.37).Conclusions: This is the first report showing that CAT C262T polymorphism is not a genetic predisposing factor for the risk of leukemia in the Turkish population. However, additional research is needed to confirm these findings.

9 September 2014 in Journal of Clinical and Experimental Investigations
Verified
Journal Article
Open access
EAEtem Akbaş
Etem Akbaş
FYFaik Gürkan Yazıcı
Faik Gürkan Yazıcı
HDHÜSEYİN DURUKAN
HÜSEYİN DURUKAN
HTHarika Topal
Harika Topal
NENazan Eras-Erdogan
Nazan Eras-Erdogan
In this study, cytogenetic and clinic findings of 46,X,i(Xq) and 45,X/46,X,i(Xq) which are the rare types of Turner syndrome are evaluated. Two patients were directed to the Cytogenetic Laboratory from Gynecology Clinic with chromosomal anomaly indication. Their peripheric blood samples are analyzed karyotypically using Giemsa-Tripsin Bantama method.\ud \ud Case 1. The patient is 17 years old, has short height, a low-posterior hairline, short neck, small and wide apart breasts, normal external genitals and underdeveloped internal genitals. Her karyotype was 45,X/46,X,i(Xq).\ud Case 2. The patient is 19 years old, has primer amenore, short height, a low-posterior hairline, wide apart and underdeveloped breasts, normal external genitals, underdeveloped uterus, obscure ovarium. Her karyotype was determined to be 46,X,i(Xq). Although symptoms progress slightly weaker, our 45,X/46,X,i(Xq) and 46,X,i(Xq) cases, which are rare types of Turner Syndrome, are generally consistent with phenotypic findings of Turner syndrome. J Clin Exp Invest 2014; 5 (3): 444-44

22 March 2021 in Molecular Syndromology
Verified
Journal Article
Closed access
PDF file
NENazan Eras-Erdogan
Nazan Eras-Erdogan
YCYalcin Celik
Yalcin Celik
Raine syndrome (RS) is a rare genetic disorder characterized by osteosclerotic bone dysplasia caused by a homozygous mutation, compound heterozygous mutation, or microdeletion in the FAM20C gene. In the present study, the MiSeq next-generation sequencing platform was used to perform the FAM20C gene sequence analysis. A novel homozygous variant c.1255T>C (p.W419R) in the FAM20C gene was diagnosed, and a nonlethal RS phenotype was confirmed, thus contributing to the expansion of the nonlethal RS phenotype. Since there is limited information about rare diseases, we believe that these studies will contribute to the literature and to the understanding of how these disorders develop and progress.